1. Waalkes,M.P., Diwan,B.A., Weghorst,C.M., Ward,J.M. and Rice,J.M. (1991) Anti-carcinogenic effects of cadmium in B6C3F1 mouse liver and lung. Toxicol. Appl. Pharmacol., 110, 327–335.
2. Waalkes,M.P., Diwan,B.A., Weghorst,C.M., Ward,J.M., Rice,J.M., Cherian,M.G. and Goyer,R.A. (1993) Further evidence of the tumor-suppressive effects of cadmium in the B6C3F1 mouse liver and lung; late stage vulnerability of tumors to cadmium and the role of metallothionein. J. Pharmacol. Exp. Ther., 266, 1656–1663.
3. Waalkes,M.P., Diwan,B.A., Rehm,S., Moussa,M., Cherian,M.G. and Goyer,R.A. (1996) Down-regulation of metallothionein expression in human and murine hepatocellular tumors; association with the tumor-necrotizing and antineoplastic effect of cadmium in mice. J. Pharmacol. Exp. Ther., 277, 1026–1033.
4. Matsumoto,Y., Oka,M., Sakamoto,A., Narasaki,F., Fukuda,M., Takatani,H., Terashi,K., Tsurutani,J., Nagashima,S., Soda,H. and Kohno,S. (1997) Enhanced expression of metallothionein in human non-small-cell lung carcinomas following chemotherapy. Anticancer Res., 17, 3777–3780.
5. Lohmann,R.D. and Beyersmann,D. (1994) Effects of zinc and cadmium on apoptotic DNA fragmentation in isolated bovine liver nuclei. Environ. Health Perspect., 102, 269–271.